[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-334101-105":59,"doc-detail-334101-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","expression-of-tspan1-and-its-link-to-thyroid-nodules-one-step-forward-on-the-path-to-thyroid-tumorigenesis-biomarkers","Expression of TSPAN1 and its link to thyroid nodules - one step forward on the path to thyroid tumorigenesis biomarkers","","Thyroid cancer is the most common endocrine malignancy and requires reliable biomarkers to distinguish tumor types for accurate diagnosis. This study evaluated TSPAN1 at both mRNA and protein levels in plasma and tissue from individuals with thyroid nodules. In a case-control design, TSPAN1 was measured by ELISA and SYBR-Green real-time PCR to compare papillary thyroid cancer, benign lesions, and healthy controls.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/expression-of-tspan1-and-its-link-to-thyroid-nodules-one-step-forward-on-the-path-to-thyroid-tumorigenesis-biomarkers/334101/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/expression-of-tspan1-and-its-link-to-thyroid-nodules-one-step-forward-on-the-path-to-thyroid-tumorigenesis-biomarkers/334101.png","ImageObject",300,407,{"name":92,"@type":93},"Eden","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":44},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main aim of this study on TSPAN1?","Question",{"text":112,"@type":113},"To examine TSPAN1 mRNA and protein levels in plasma and tissue from patients with thyroid nodules and determine whether it can help distinguish papillary thyroid cancer from benign and healthy conditions.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was TSPAN1 measured in the case-control study?",{"text":117,"@type":113},"TSPAN1 was assessed at the protein level using ELISA and at the mRNA level using SYBR-Green real-time PCR.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic performance was reported for detecting papillary thyroid cancer?",{"text":121,"@type":113},"TSPAN1 showed sensitivity of 76.7% and specificity of 65.4% for detecting PTC from healthy plasma at the cutoff value \u003C 2.7 ng/ml.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},334101,1790153285,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":44,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":4},1374391974468,"https://ap-avatar.wpscdn.com/davatar_29158cc5080c5b710cf443261637dec0","Abooshahab et al. BMC Cancer (2024) 24:1414 BMC Cancer  \n[https://doi.org/10.1186/s12885-024-13176-8](https://doi.org/10.1186/s12885-024-13176-8)  \nRESEARCH Open Access  \nExpression ofTSPAN1 and its link to thyroid nodules: one step forward on the path to thyroid tumorigenesis biomarkers  \nRaziyeh Abooshahab 1,2, Maryam Zarkesh 1*, Marzieh Sameni3,4, Mahdi Akbarzadeh 1, Fatemeh Skandari5 and Mehdi Hedayati 1*  \nAbstract  \nBackground Thyroid cancer is ranked as the most common malignancy within the endocrine system and the seventh most prevalent cancer in women globally. Thyroid malignancies require evaluating biomarkers capable of distinguishing between them for accurate diagnosis. We examined both mRNA and protein level s ofTSPAN1 in plasma and tissue samples from individuals with thyroid nodules to aid this endeavour.  \nMethods In this case-control study, TSPAN1 was assessed at both protein and mRNA levels in 90 subjects, including papillary thyroid cancer (PTC; N= 60), benign (N = 30), and healthy subjects (N = 26) using enzyme-linked immunosorbent assay (ELISA) and SYBR-Green Real-Time PCR, respectively.  \nResults TSPAN1 plasma levels were decreased in PTC and benign compared to healthy subjects (P = 0 . 002) . TSPAN1 mRNA levels were also decremented in the tumoral compared to the paired normal tissues (P = 0 . 012); this drop was also observed in PTC patients compared to benign patients (P = 0 . 001) . Further, TSPAN1 had an appropriate diagnostic value for detecting PTC patients from healthy plasma samples with a sensitivity of 76 . 7% and specificity of 65 .4% atthe cutoff value \u003C 2.7 (ng/ml) .  \nConclusion TSPAN1 levels are significantly reduced in patients with benign and PTC, demonstrating its potential value as a diagnostic biomarker. Additionally, the significant reduction in TSPAN1 mRNA expression within PTC tumor tissues may suggest its involvement in tumor progression and development. Further studies, including larger-scale validation studies and mechanistic investigations, are imperative to clarify the molecular mechanisms behind TSPAN1 and, ultimately, its clinical utility for treating thyroid disorders.  \nKeywords Biomarkers, Benign lesions, Extracellular matrix, Papillary thyroid cancer, Tetraspanin 1  \n*Correspondence: Maryam Zarkesh  \n[zarkesh@endocrine.ac.ir](zarkesh@endocrine.ac.ir); [zarkesh1388@gmail.com](zarkesh1388@gmail.com)  \nMehdi Hedayati  \n[hedayati@endocrine.ac.ir](hedayati@endocrine.ac.ir); [hedayati47@gmail.com](hedayati47@gmail.com)  \n1Cellular and Molecular Endocrine Research Center, Research Institute for Endocrine Sciences, Shahid Beheshti University of Medical Sciences, PO Box: 19395-4763, Tehran, Iran  \n2Curtin Medical School, Curtin University, Bentley 6102, Australia 3Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran  \n4Zhino-Gene Research Services Co, Tehran, Iran  \n5Department of Stem Cell and Regenerative Medicine Group, National Institute of Genetic Engineering and Biotechnology, Tehran, Iran  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain pe","cbCaicRwIQVvmhEM","https://ap.wps.com/l/cbCaicRwIQVvmhEM","pdf",1284821,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Keywords\n# Introduction","[{\"question\":\"What was the main aim of this study on TSPAN1?\",\"answer\":\"To examine TSPAN1 mRNA and protein levels in plasma and tissue from patients with thyroid nodules and determine whether it can help distinguish papillary thyroid cancer from benign and healthy conditions.\"},{\"question\":\"How was TSPAN1 measured in the case-control study?\",\"answer\":\"TSPAN1 was assessed at the protein level using ELISA and at the mRNA level using SYBR-Green real-time PCR.\"},{\"question\":\"What diagnostic performance was reported for detecting papillary thyroid cancer?\",\"answer\":\"TSPAN1 showed sensitivity of 76.7% and specificity of 65.4% for detecting PTC from healthy plasma at the cutoff value \\u003c 2.7 ng/ml.\"}]","Expression of TSPAN1 and its link to thyroid nodules - one step forward on the path to thyroid tumorigenesis biomarkers | PDF",1790005260,23]